Sarepta Therapeutics Stock Price - SRPT

2.48 (1.71%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Sarepta Therapeutics Inc New SRPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
2.48 1.71% 147.49 141.00 148.74 144.88 145.01 10:40:11
Bid Price Ask Price Spread Spread % News
147.46 147.74 0.28 0.19% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,984 113,809 $ 146.10 $ 16,626,980 953,419 72.05 - 158.80
Last Trade Time Type Quantity Stock Price Currency
10:40:09 19 $ 147.4801 USD

Sarepta Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 11.31B 77.99M 62.58M $ 380.83M $ - -9.68 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Sarepta Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SRPT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week152.98154.95141.00149.70744,551-5.49-3.59%
1 Month125.15158.40123.6631144.011,066,51022.3417.85%
3 Months97.95158.4078.06118.26909,12249.5450.58%
6 Months111.26158.4078.06120.741,006,25936.2332.56%
1 Year119.90158.8072.05113.961,229,45127.5923.01%
3 Years31.49176.5030.0992.801,422,826116.00368.37%
5 Years25.38176.508.0055.762,010,279122.11481.13%

Sarepta Therapeutics Description

Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.